Broad Street Angels Hears Pitches from 3 Female CEO Entrepreneurs
Startups are alive and well and run by women at July’s Broad Street Angels investment meeting.
Philadelphia, PA – Open for business and selecting high growth companies to pitch its members for investment, the Broad Street Angels held its July investment meeting with a lineup of 3 dynamic female CEO led companies.
Stimulus – a relationship intelligence platform that uses data & analytics to help companies make better purchasing decisions. We leverage API’s from internal and external data sources to provide visibility, enhance decision-making and to promote communication of supplier utilization. This allows teams to avoid risks and save costs by identifying business opportunities and disruptions across the supply chain. Tiffanie Stanard, CEO
CytoAgents – a clinical-stage biotech company focused on the development of innovative pharmaceutical products for the treatment of COVID-19, influenza, viral infectious diseases and conditions that cause acute respiratory distress. Our lead compound, GP1681, targets the underlying cause of life-threatening respiratory distress, cytokine release syndrome, by modulating the body’s natural immune response to sickness or disease. Teresa Whalen, CEO